South State Corp Gilead Sciences, Inc. Transaction History

South State Corp

$1.45 Billion
Q3 2024

A detailed history of South State Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, South State Corp holds 12,010 shares of GILD stock, worth $1.13 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

12,010

Previous 14,594 17.71%

Holding current value

$1.13 Million

Previous $1 Million 0.5%

% of portfolio

0.07%

Previous 0.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$66.59 - $83.99 $172,068 - $217,030	-2,584 Reduced 17.71%	12,010 $1.01 Million
Q2 2024 Aug 02, 2024	SELL	$63.15 - $72.88 $99,840 - $115,223	-1,581 Reduced 9.77%	14,594 $1 Million
Q1 2024 May 06, 2024	SELL	$71.58 - $87.29 $135,071 - $164,716	-1,887 Reduced 10.45%	16,175 $1.18 Million
Q4 2023 Feb 06, 2024	SELL	$73.27 - $83.09 $300,260 - $340,502	-4,098 Reduced 18.49%	18,062 $1.46 Million
Q3 2023 Nov 07, 2023	SELL	$73.94 - $80.67 $330,363 - $360,433	-4,468 Reduced 16.78%	22,160 $1.66 Million
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $378,073 - $431,245	-4,974 Reduced 15.74%	26,628 $2.05 Million
Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $291,999 - $332,678	-3,777 Reduced 10.68%	31,602 $2.62 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $186,149 - $267,246	-2,987 Reduced 7.79%	35,379 $3.04 Million
Q3 2022 Nov 07, 2022	SELL	$59.54 - $68.01 $103,540 - $118,269	-1,739 Reduced 4.34%	38,366 $2.37 Million
Q2 2022 Aug 05, 2022	SELL	$57.72 - $65.01 $81,442 - $91,729	-1,411 Reduced 3.4%	40,105 $2.48 Million
Q1 2022 May 06, 2022	BUY	$57.92 - $72.58 $44,656 - $55,959	771 Added 1.89%	41,516 $2.47 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $67,669 - $76,806	1,043 Added 2.63%	40,745 $2.96 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $11,778 - $12,707	174 Added 0.44%	39,702 $2.77 Million
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $20,437 - $22,330	-322 Reduced 0.81%	39,528 $2.72 Million
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $131,400 - $149,927	-2,190 Reduced 5.21%	39,850 $2.58 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $645,356 - $735,353	-11,392 Reduced 21.32%	42,040 $2.45 Million
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $43,345 - $54,499	698 Added 1.32%	53,432 $3.38 Million
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $410,746 - $476,952	5,678 Added 12.07%	52,734 $4.06 Million
Q1 2020 May 04, 2020	BUY	$62.63 - $80.22 $557,469 - $714,038	8,901 Added 23.33%	47,056 $3.52 Million
Q4 2019 Feb 05, 2020	BUY	$61.62 - $67.78 $289,798 - $318,769	4,703 Added 14.06%	38,155 $2.48 Million
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $2.09 Million - $2.31 Million	33,452 New	33,452 $2.12 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $208,923 - $272,629	-3,451 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $281,484 - $311,655	-3,949 Reduced 53.36%	3,451 $267,000
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $20,891 - $24,368	-322 Reduced 4.17%	7,400 $524,000
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $48,438 - $59,052	-665 Reduced 7.93%	7,722 $582,000
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $173,748 - $203,955	-2,442 Reduced 22.55%	8,387 $601,000
Q3 2017 Nov 09, 2017	SELL	$72.11 - $85.47 $29,492 - $34,957	-409 Reduced 3.64%	10,829 $877,000
Q2 2017 Aug 10, 2017	BUY	N/A	11,238	11,238 $795,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.

Account